![Holger Liepmann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Holger Liepmann
Presidente en
F3 Platform Biologics, Inc.
.
Perfil
Holger A. Liepmann is currently the Chairman of F3 Platform Biologics, Inc. and a Director at PanTheryx, Inc., Desert Research Institute Foundation, and SmartTots.
He previously held positions as Chairman at Abbott GmbH (Germany), Director at Verenium Corp., Enzymotec Ltd., and Altan Pharma Ltd., and Executive Vice President at Abbott Laboratories and Pharmaceutical Products.
He was also a Senior Vice President at Abbott International LLC and a Marketing Manager-Europe at Cutter Laboratories, Inc. Liepmann received his undergraduate degree from Dartmouth College and his MBA from Stanford University.
Cargos activos de Holger Liepmann
| Empresas | Cargo | Inicio |
|---|---|---|
Desert Research Institute Foundation
 Desert Research Institute Foundation Miscellaneous Commercial ServicesCommercial Services Supports environmental science research to maximize DRI's impact on improving people's lives | Director/Miembro de la Junta | - |
SmartTots | Director/Miembro de la Junta | - |
PanTheryx, Inc.
 PanTheryx, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes nutritional supplements | Director/Miembro de la Junta | 10/04/2020 |
F3 Platform Biologics, Inc.
 F3 Platform Biologics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops novel therapeutics | Presidente | - |
Antiguos cargos conocidos de Holger Liepmann.
| Empresas | Cargo | Fin |
|---|---|---|
Altan Pharma Ltd.
 Altan Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets injectable medications | Director de Operaciones | 02/01/2021 |
| VERENIUM CORP | Director/Miembro de la Junta | 31/10/2013 |
Abbott International LLC | Corporate Officer/Principal | 02/01/2011 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01/01/2011 |
Pharmaceutical Products | Corporate Officer/Principal | - |
Formación de Holger Liepmann.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
94
Relaciones de 1er grado
14
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 14 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
PanTheryx, Inc.
PanTheryx, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes nutritional supplements | Health Technology |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abbott GmbH (Germany)
 Abbott GmbH (Germany) Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical, diagnostic, nutritional, and hospital products | Health Technology |
Verenium Corp.
 Verenium Corp. BiotechnologyHealth Technology Produces cellulosic ethanol derived from multiple biomass feedstocks | Health Technology |
Pharmaceutical Products | |
Desert Research Institute Foundation
Desert Research Institute Foundation Miscellaneous Commercial ServicesCommercial Services Supports environmental science research to maximize DRI's impact on improving people's lives | Commercial Services |
Enzymotec Ltd.
 Enzymotec Ltd. BiotechnologyHealth Technology Develops, manufactures and markets lipid-based bioactive ingredients | Health Technology |
Abbott International LLC | |
Cutter Laboratories, Inc. | |
Altan Pharma Ltd.
Altan Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets injectable medications | Health Technology |
SmartTots | |
F3 Platform Biologics, Inc.
F3 Platform Biologics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops novel therapeutics | Health Technology |
- Bolsa de valores
- Insiders
- Holger Liepmann
